ICSI treatment linked to increased prostate cancer risk

Men who undergo ICSI (intracytoplasmic sperm injection) are at greater risk of developing prostate cancer, according to a large study presented during the European Society of Human Reproduction and Embryology annual meeting.Medical Xpress
Source: Society for Endocrinology - Category: Endocrinology Source Type: news

Related Links:

People who eat dinner before 9 p.m. -- or at least two hours before going to sleep -- have a 20% lower risk of breast and prostate cancer than those who eat after 10 p.m. or go to bed shortly after supper, researchers found.
Source: CNN.com - Health - Category: Consumer Health News Source Type: news
Condition:   Prostate Cancer Intervention:   Radiation: SABR Sponsor:   Sunnybrook Health Sciences Centre Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Researchers will investigate environmental and genetic factors related to aggressiveness of prostate cancer in African-American men.
Source: National Institutes of Health (NIH) News Releases - Category: American Health Source Type: news
Authors: Dewar M, Kaestner L, Zikhali Q, Jehle K, Sinha S, Lazarus J Abstract BACKGROUND: Men with West African ancestry living in Europe and North America are at higher risk of being diagnosed with prostate cancer, are diagnosed at a younger age, and have more severe disease characteristics. Published reports present a conflicting picture of the disease in sub-Saharan Africa. We aimed to study the clinical and pathological features of men undergoing prostate biopsy from different racial backgrounds in South Africa in an attempt to characterise the disease locally. Our hypothesis was that black African men presenti...
Source: South African Journal of Surgery - Category: Surgery Tags: S Afr J Surg Source Type: research
PROSTATE cancer symptoms include having a sudden urge to pass urine, and using the toilet more often than normal. But do you do this when you pee? Signs and treatment for prostate cancer revealed.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
(Louisiana State University Health Sciences Center) LSU Health New Orleans is one of 12 universities and health care entities conducting the first large-scale, multi-institutional study to help determine why African- American men are at higher risk for developing aggressive prostate cancer and dying from it.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
(Johns Hopkins Medicine) Johns Hopkins Kimmel Cancer Center will participate in a $26.5 million effort to conduct the first large-scale, multi-institutional study on African-American men with prostate cancer to better understand why they are at higher risk for developing more aggressive forms of the disease and why they are more likely to die from it.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
(University of Southern California - Health Sciences) The Keck School of Medicine of USC is leading a $26.5 million effort to conduct the first large-scale, multi-institutional study on African-American men with prostate cancer.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
(Natural News) Men who want to significantly reduce their risk of dying from prostate cancer could start by skipping burgers, French fries, or fatty food altogether. Researchers from the Cancer Center at Beth Israel Deaconess Medical Center (BIDMC) published a study in two journals, Nature Genetics and Nature Communications, and have reported that the typical...
Source: NaturalNews.com - Category: Consumer Health News Source Type: news
AbstractTo describe the evolution of robotic laparoendoscopic single-site radical prostatectomy (R-LESS-RP) performed with the daVinci Single-Site Platform ® and a home-made multiport aimed to overcome classical drawbacks of LESS, still present with this platform. Between 09/2015 and 06/2017 12 patients underwent R-LESS RP for clinical localized prostate cancer. Following a “phase 1 (development-stage)” innovation, development, exploration, assess ment, long-term study (IDEAL) framework, different solutions were drawn to overcome drawbacks of daVinci Single-Site Platform®, included 3 (A, B, and C) multi...
Source: Journal of Robotic Surgery - Category: Surgery Source Type: research
More News: Cancer | Cancer & Oncology | Endocrinology | ICSI (Intracytoplasmic Sperm Injection) | Prostate Cancer | Reproduction Medicine | Study